American Society of Nephrology

Kidney Week 2017 in New Orleans. The American Society of Nephrology Annual Meeting and Scientific Exposition welcomes more than 13,000 kidney professionals from around the world to this premier kidney meeting.

We provide coverage from the meeting on topics such as:

• Rapid Correction of Severe Hyponatremia
• Tolvaptan Improved Hyponatremia in Patient with Melanoma
• Options Education Impacts Modality Choice for ESRD Patients
• Fluid Overload and AKI and Mortality in Influenza Patients
• Hyponatremia and Impaired Cognitive Function: SPRINT Baseline Data
• Early Mortality in Continuous Renal Replacement Therapy
• Case Report: Patient with Hyponatremia after New Anti-VEGF Therapy
• Use of Statins in Patients with Non-Dialysis Dependent CKD
• Hyponatremia in Newly Diagnosed Dengue Infection

View the meeting program here:

https://www.asn-online.org/education/kidneyweek/2017/meeting-overview.aspx

Pathways Associated with Hyperuricemia in Hispanic Children

New Orleans—Hyperuricemia in children is known to be predictive of hypertension in adulthood. Researchers studied 260 Hispanic children (130 with hyperuricemia and 130 without hyperuricemia) from the Viva La Familia study to identify urinary metabolites and pathways associated with hyperuricemia. A total of 703 metabolites were identified; of those, 377 were significantly different between the two groups. Key differences were ... Read More »

Pegloticase Decreases in MAP in Patients with Chronic Gout

New Orleans—In an analysis of results from randomized clinical trials of pegloticase, researchers examined the impact of persistent, very low levels of serum uric acid on blood pressure in patients with chronic refractory gout. The analysis included data on 29 responders whose mean arterial pressure (MAP) at baseline was 94.9 mm Hg. Throughout the 6-month trial, there were significant reductions ... Read More »

ADPKD Patients with Advanced CKD at Increased Risk of Adverse Outcomes

New Orleans—Patients with autosomal dominant polycystic kidney disease (ADPKD) develop progressive chronic kidney disease (CKD) and a subsequent increased risk for adverse events that include cardiovascular disease, infections, end-stage renal disease (ESRD), and mortality. There are few data available on the risks of adverse events in patients with ADPKD and advanced CKD. Manish M. Sood, MD, and colleagues conducted a ... Read More »

Fluid Overload and AKI and Mortality in Influenza Patients

New Orleans—In a subset of critically ill patients with influenza, particularly A(H1N1), the influenza virus has been consistently associated with high mortality in patients who develop Acute Distress Respiratory Syndrome (ADRS).  There are few available data on the risk factors for this association. There have been studies documenting the association of fluid overload and an increase in the incidence of ... Read More »

Identifying Rapid Progression in Patients with ADPKD

New Orleans—The most frequently inherited kidney disease is autosomal dominant polycystic kidney disease (ADPKD). The progressive cyst growth associated with ADPKD, combined with interstitial damage, causes progressive kidney failure; there is wide variation of the severity of ADPKD among this patient population. The European Medicines Agency has approved tolvaptan for adults with CKD stage 1 to 3 at baseline who ... Read More »

Predicting Hyponatremia from Electronic Medical Records

New Orleans—In both hospitalized and ambulatory patients, hyponatremia is associated with increased morbidity and mortality. Utilizing electronic medical records (EMRs) to identify patients at high risk for hyponatremia may have significant impact on patient outcomes, according to Young-Il Jo, MD, and Sug kyun Shin, MD. Identification of high-risk patients can also serve to support clinical decision making the management of ... Read More »

Biomarkers for Early Diagnosis of AKI in Critically Ill Patients

New Orleans—Hospitalized patients may experience acute kidney injury (AKI), a condition that is more common among patients in the intensive care unit (ICU). Serum creatinine measurement can be used to assess AKI; however, according to Luana A. Pedroso, MD, and colleagues, serum creatinine is a poor and delayed marker of AKI. In recent decades, new circulating and urinary biomarkers have ... Read More »

Pathways and Biomarkers for Progression of Diabetic Kidney Disease

New Orleans—The leading cause of end-stage renal disease (ESRD) is diabetic kidney disease. According to researchers, understanding of molecular pathways involved in the initiation and progression of diabetic kidney disease facilitates development of biomarkers and identification of drug targets. Skander Mulder, MD, and colleagues conducted a study designed to identify molecular pathways associated with progressive loss of kidney function in ... Read More »

Early Mortality in Continuous Renal Replacement Therapy

New Orleans—In patients with acute kidney injury (AKI) who are hemodynamically unstable, the treatment modality of choice is continuous renal replacement therapy (CRRT). However, according to researchers, the mortality rate in AKI in intensive care units is high despite the use of CRRT. Haewon Lee, MD, and colleagues in the Republic of Korea conducted a retrospective observational study designed to ... Read More »

Hyponatremia and Impaired Cognitive Function: SPRINT Baseline Data

New Orleans—There are limited data exploring the association between hyponatremia and reversible cognitive impairment. Researchers, led by Daniel E. Weiner, MD, recently conducted an analysis of baseline data from the SPRINT (Systolic Blood Pressure Intervention) cognition substudy (SPRINT-MIND) to examine the relationship between serum sodium concentration and cognitive function. They reported results during a poster session at Kidney Week 2017 ... Read More »